{"title":"A Case Report on Aggressive Breast Cancer","authors":"Kundana Rayamajhi, R. Ghimire, B. Kayastha","doi":"10.3126/njr.v13i1.57833","DOIUrl":null,"url":null,"abstract":"Human epidermal growth factor receptor-2 (HER 2) positive breast cancers represent a highly aggressive breast cancer subtype and are associated witha worse prognosis. They tend to be more aggressive with lower survival rates but with a better prognosis than the triple-negative subtype.","PeriodicalId":178516,"journal":{"name":"Nepalese Journal of Radiology","volume":"10 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nepalese Journal of Radiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3126/njr.v13i1.57833","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Human epidermal growth factor receptor-2 (HER 2) positive breast cancers represent a highly aggressive breast cancer subtype and are associated witha worse prognosis. They tend to be more aggressive with lower survival rates but with a better prognosis than the triple-negative subtype.